Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
04/19/1995 | EP0648218A1 Therapeutic nucleosides |
04/19/1995 | EP0648127A1 Type i and type ii surface antigens associated with staphylococcus epidermidis |
04/19/1995 | EP0648119A1 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS) |
04/19/1995 | EP0517796B1 Oligonucleotide analogs |
04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
04/19/1995 | CN1028230C Process for preparing benzoheterocyclic compounds |
04/19/1995 | CN1028206C Purification of pertussis antigens |
04/18/1995 | US5407961 α-substituted benzenemethanamine derivatives and pharmaceutical use |
04/18/1995 | US5407952 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases |
04/18/1995 | US5407943 Azaspiro quinolone antibacterial agents |
04/18/1995 | US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders |
04/18/1995 | US5407931 Bactericides |
04/18/1995 | US5407929 Triazolylthiomethylthio cephalosporin hydrochhloride, its crystalline hydrate and the production of the same |
04/18/1995 | US5407688 Compositions and methods for treating gastrointestinal disorders |
04/18/1995 | CA1335268C Methods of technetium/rhenium labeling of proteins |
04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
04/13/1995 | WO1995009867A1 Antifungal compositions |
04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
04/13/1995 | WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
04/13/1995 | WO1995009847A1 Pyrimidineamine derivatives and processes for the preparation thereof |
04/13/1995 | WO1995009843A1 Hiv protease inhibitors |
04/13/1995 | WO1995009638A1 Improvements relating to antibacterial compositions |
04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
04/13/1995 | WO1995009601A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
04/13/1995 | WO1995007934A3 Il8 inhibitors |
04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
04/13/1995 | CA2173502A1 Antifungal compositions |
04/13/1995 | CA2173109A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
04/13/1995 | CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
04/13/1995 | CA2169084A1 Improvements relating to antibacterial compositions |
04/13/1995 | CA2148931A1 Pyrimidineamine derivatives and processes for the preparation thereof |
04/12/1995 | EP0647644A1 Antibacterial pyrido 1,2,3-d,e 1,3,4 benzoxacin derivatives |
04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
04/12/1995 | EP0647230A1 Cephalosporins and 1-carba-1-dethia cephalosporins |
04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
04/12/1995 | EP0561827B1 Tetrapeptides deriving from dalbaheptide antibiotics |
04/12/1995 | CN1101289A Live combination vaccine |
04/11/1995 | US5405939 2',5'-phosphorothioate oligoadenylates and their covalent conjugates with polylysine |
04/11/1995 | US5405938 Sequence-specific binding polymers for duplex nucleic acids |
04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
04/11/1995 | US5405862 Low free formaldehyde methylolhydantoin compositions |
04/11/1995 | US5405861 Triazole compounds and antifungal compositions thereof |
04/11/1995 | US5405844 Tetracyclic antibiotics and processes for their preparation |
04/11/1995 | CA1335201C S-adenosyl methionine inhibitors |
04/06/1995 | WO1995009175A1 Ring-expanded nucleosides and nucleotides |
04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
04/06/1995 | WO1995008993A1 Oral formulations of an antifungal |
04/06/1995 | WO1995008920A1 Substantive antimicrobial phosphates |
04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
04/05/1995 | EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis |
04/05/1995 | EP0646598A1 New pseudopeptides with antiviral activity containing valine |
04/05/1995 | EP0646597A1 New pseudopeptides with antiviral activity containing valine |
04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
04/05/1995 | EP0646125A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
04/05/1995 | EP0646004A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
04/05/1995 | CN1101044A 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents |
04/05/1995 | CN1100931A Treatment of viral infections |
04/05/1995 | CN1028106C Therapeutic nucleosides |
04/04/1995 | US5403830 Compositions and methods of treating gastrointestinal disorders |
04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
04/04/1995 | US5403594 Oral spiramycin formulations and method for preparing same |
04/04/1995 | CA1335103C 5'-indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted) phenyl-5beta- amidomethyloxazolidin-2-ones and 3-(nitrogen substituted) phenyl-5beta-amidomethyloxazolidin-2-ones |
04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
04/04/1995 | CA1335078C Antiviral method for human immunodeficiency virus with bu-3608 |
03/30/1995 | WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
03/30/1995 | WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
03/30/1995 | WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates |
03/30/1995 | WO1995008552A1 Novel substituted propane-2-ol derivatives |
03/30/1995 | WO1995008541A1 Conformationally locked nucleoside analogues |
03/30/1995 | WO1995008540A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents |
03/30/1995 | WO1995008344A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
03/30/1995 | WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof |
03/30/1995 | CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
03/30/1995 | CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
03/30/1995 | CA2170521A1 Immunoreactive antigens of hepatitis e virus |
03/29/1995 | EP0645141A1 Treating water for dermatoses in domestic animals |
03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
03/29/1995 | EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
03/29/1995 | EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof |
03/29/1995 | EP0644886A1 3-substituted carbacephems |
03/29/1995 | EP0644883A1 Enniatines and enniatine derivates used to control endoparasites |
03/29/1995 | EP0644869A1 Ion pairs of hypericin compounds having antiviral activity |